A New Perspective on Cerebral Blood Vessels, NeuFlow

We provide accurate diagnostics with the world's first 3D color MRA technology.
Experience a personalized brain health guide powered by our FDA-approved, proprietary algorithm solution.

mobile background
A New Perspective on Cerebral Blood Vessels, NeuFlow

We provide accurate diagnostics with the world's first 3D color MRA technology. 

Experience a personalized brain health guide powered by our FDA-approved, proprietary algorithm solution.

NeuFlow
The world’s first diagnostic system for COLOR MRA imaging.

A groundbreaking medical technology that transforms 2D black-and-white MRA into 3D color analysis supported by quantitative data.

A next-generation brain vessel analysis solution integrating the advantages of both CFD and PC-MR technologies.

Quick and convenient detection of major cerebrovascular risk factors, including cerebral infarction, stroke, and aneurysms.

NeuFlow
The world’s first diagnostic system
for COLOR MRA imaging.

A groundbreaking medical technology that transforms 2D black-and-white MRA into 3D color analysis supported by quantitative data.

A next-generation brain vessel analysis solution integrating the advantages of both CFD and PC-MR technologies.

Quick and convenient detection of major cerebrovascular risk factors, including cerebral infarction, stroke, and aneurysms. 

What is NeuFlow?

NeuFlow is a medical device that analyzes conventional 2D black-and-white MRA (Magnetic Resonance Angiography) images using 3D color imaging and data-driven insights, enabling a more accurate assessment of cerebrovascular health.

Certification Information:
FDA Clearance (510k): K240385
Korea MFDS Approval: No. 23-4077

Certification Information : FDA Clearance (510k): K240385

Korea MFDS Approval: No. 23-4077

Limitations of
Conventional MRA

기존 흑백 MRA 이미지
  • Many cases are assessed as normal based solely on 2D imaging, potentially overlooking underlying issues.
  • Accurate detection of cerebrovascular abnormalities is challenging.
  • Merely identifying risk factors is not enough.
  • Patients may feel unsatisfied with a simple 'no abnormality' result.


NeuFlow's Solution

NeuFlow 3D 컬러 MRA 이미지
  • Enables intuitive analysis through 3D color imaging.
  • Provides accurate diagnostics by quantifying hemodynamic data (SIG).
  • Delivers individualized guidance for brain vessel health.
  • Enhances patient satisfaction through comprehensive health insights.
Key Features and
Functions of NeuFlow

3D color imaging and
quantified SIG data

Performs quantitative analysis of hemodynamic properties across the entire cerebrovascular system as well as specific vessels.

Compatible with
PACS systems

Supports efficient clinical workflows through full integration with existing hospital systems.

3D/2D Image
Overlay Feature

Enables accurate localization by overlaying 2D slices with 3D color vascular images.

Provides
hemodynamic data

Quantitative analysis of blood flow characteristics through Signal Intensity Gradient (SIG)

Cerebral Vessel
Health Report

Providing Big Data–Driven Reports on
Cerebral Vessel Health

Personalized
AI Health Guide

Delivers individualized cerebrovascular health management guidance powered by big data analytics.

NeuFlow’s
Technological Superiority
01. Hemodynamic Data (SIG)

Signal Intensity Gradient (SIG) is an FDA- and MFDS-approved indicator for analyzing blood flow characteristics, allowing for the quantitative assessment of cerebrovascular health.

02. Three-dimensional vascular color mapping technology

Through a proprietary algorithm, conventional 2D black-and-white MRA images are transformed into 3D color representations, enabling intuitive visualization of blood flow characteristics.

03. FDA Approved

NeuFlow is the only device to obtain FDA 510(k) clearance based on Substantial Equivalence.

NeuFlow
Areas of Application and Clinical Benefits
NeuFlow’s Technological Superiority

01. Hemodynamic Data (SIG)

Signal Intensity Gradient (SIG) is an FDA- and MFDS-approved indicator for analyzing blood flow characteristics, allowing for the quantitative assessment of cerebrovascular health.

02. Three-dimensional vascular color mapping technology

Through a proprietary algorithm, conventional 2D black-and-white MRA images are transformed into 3D color representations, enabling intuitive visualization of blood flow characteristics.

03. FDA Approved

NeuFlow is the only device to obtain FDA 510(k) clearance based on Substantial Equivalence.

Conditions That Can Be Assessed

Moyamoya disease

Cerebral aneurysm

Cerebral infarction

Cerebral Small Vessel Disease

Association with Risk Factors  

Hypertension

Diabetes

Hyperlipidemia

Obesity / Smoking

Clinical Study Results 

Forecasting the progression of Moyamoya disease


Reference : Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease. Stroke. 2020

Forecasting outcomes in cerebral infarction 


Reference : Cerebral artery signal intensity gradient from Time-of-Flight Magnetic Resonance Angiography and clinical outcome in lenticulostriate infarction. Front Neurol. 2023

Measuring the risk of cerebral aneurysm rupture


Reference : Geometric versus Hemodynamic Indexes for Rupture-Destined Aneurysms. Cerebrovasc Dis. 2024

NeuFlow Operation Process
1
TOF-MRA 소스 이미지
2
3D 뇌혈관 이미지 구현
3
혈류(SIG) 색채화
4
ROI 측정
5
뇌혈관 건강보고서
TOF-MRA 소스 이미지
기존 촬영된 MRA 영상 활용
3D 뇌혈관 이미지 구현
3차원 혈관 구조 생성
혈류(SIG) 색채화
혈류역학 데이터 시각화
ROI 측정
관심 영역 정량 분석
뇌혈관 건강보고서
맞춤형 건강 가이드 생성
1
TOF-MRA Source Image
TOF-MRA 소스 이미지
Use of Existing MRA Scans
2
3D Reconstruction of
Cerebral Blood Vessels
3D 뇌혈관 이미지 구현
Generation of
3D Vascular Structures
3
Color Mapping of
Blood Flow (SIG)
혈류(SIG) 색채화
Hemodynamic Data Visualization
4
ROI Measurement
ROI 측정
ROI Quantitative Analysis
5
Cerebrovascular
Health Report
뇌혈관 건강보고서
Personalized
Health Guide Generation
NeuFlow
Benefits by User Type
의료진 관련 이미지

Advantages for Medical Staff and Hospitals

  • Accurate interpretation enabled by in-depth 3D analysis of brain vessels
  • Helps patients understand their condition more clearly
  • Offers a detailed brain vessel health report along with quantitative indices
  • Offers patient-specific guidance for proactive brain health management공
  • Promotes routine follow-up visits for ongoing brain vessel care
"It’s like viewing a PET scan for an MRA. The results are instantly visible and provide clear confidence in the diagnosis."
- The Director of Korea’s sole neurology-specialized hospital
환자/검진자 관련 이미지

Advantages for Patients and Health Screening Participants

  • Understand your brain’s blood vessels at a glance with intuitive 3D results
  • Get a clear assessment of your brain vessel health through a detailed report
  • Offers individualized brain health management plans
  • Allows for early identification and prevention of brain vessel disorders
  • Motivates health improvement through precise assessment of brain vascular health
"Being able to see my brain vessel health through color images was incredibly reassuring. I could understand the results much more clearly, and it really motivated me to take better care of my health."
- Health Checkup Client

MediImg Co., Ltd. | Est. 2018

Business License No. : 313-87-00931

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park, Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448

E-mail : info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.


Approved by the MFDS

MediImg Co., Ltd. | Est. 2018 

Business License No. : 313-87-00931 

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park,

Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448 | E-mail|info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Approved by the MFDS


Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.